236 related articles for article (PubMed ID: 22544681)
1. Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Cancer; 2012 Nov; 118(22):5623-9. PubMed ID: 22544681
[TBL] [Abstract][Full Text] [Related]
2. HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US.
Liu G; Kong L; Du P
Papillomavirus Res; 2016 Dec; 2():1-8. PubMed ID: 26623444
[TBL] [Abstract][Full Text] [Related]
3. Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Vaccine; 2013 Feb; 31(8):1138-40. PubMed ID: 23290834
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809.
American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group
Obstet Gynecol; 2020 Aug; 136(2):e15-e21. PubMed ID: 32732766
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.
Schluterman NH; Terplan M; Lydecker AD; Tracy JK
Vaccine; 2011 May; 29(21):3767-72. PubMed ID: 21440038
[TBL] [Abstract][Full Text] [Related]
7. Committee opinion no. 588: human papillomavirus vaccination.
Obstet Gynecol; 2014 Mar; 123(3):712-718. PubMed ID: 24553168
[TBL] [Abstract][Full Text] [Related]
8. The influence of deductible health plans on receipt of the human papillomavirus vaccine series.
Roblin DW; Ritzwoller DP; Rees DI; Carroll NM; Chang A; Daley MF
J Adolesc Health; 2014 Mar; 54(3):275-81. PubMed ID: 24560035
[TBL] [Abstract][Full Text] [Related]
9. A randomized intervention of reminder letter for human papillomavirus vaccine series completion.
Chao C; Preciado M; Slezak J; Xu L
J Adolesc Health; 2015 Jan; 56(1):85-90. PubMed ID: 25438965
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
11. Disparities in human papillomavirus vaccine completion among vaccine initiators.
Chou B; Krill LS; Horton BB; Barat CE; Trimble CL
Obstet Gynecol; 2011 Jul; 118(1):14-20. PubMed ID: 21691158
[TBL] [Abstract][Full Text] [Related]
12. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US.
Saxena K; Kathe N; Sardana P; Yao L; Chen YT; Brewer NT
Hum Vaccin Immunother; 2023 Dec; 19(1):2161253. PubMed ID: 36631995
[TBL] [Abstract][Full Text] [Related]
13. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
[TBL] [Abstract][Full Text] [Related]
14. Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.
Rahman M; Laz TH; McGrath CJ; Berenson AB
Clin Pediatr (Phila); 2015 Dec; 54(14):1328-33. PubMed ID: 25848128
[TBL] [Abstract][Full Text] [Related]
15. Associations between insurance-related affordable care act policy changes with HPV vaccine completion.
Hawkins SS; Horvath K; Cohen J; Pace LE; Baum CF
BMC Public Health; 2021 Feb; 21(1):304. PubMed ID: 33549075
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with human papillomavirus vaccination completion on a catch-up schedule.
Perry R; Rankin K; Yu MC; Harwood B
Obstet Gynecol; 2014 Jul; 124(1):76-81. PubMed ID: 24901268
[TBL] [Abstract][Full Text] [Related]
17. Does intention to recommend HPV vaccines impact HPV vaccination rates?
Feemster KA; Middleton M; Fiks AG; Winters S; Kinsman SB; Kahn JA
Hum Vaccin Immunother; 2014; 10(9):2519-26. PubMed ID: 25483470
[TBL] [Abstract][Full Text] [Related]
18. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: Association with initiation and completion rates.
Rutten LJ; St Sauver JL; Beebe TJ; Wilson PM; Jacobson DJ; Fan C; Breitkopf CR; Vadaparampil ST; Jacobson RM
Vaccine; 2017 Jan; 35(1):164-169. PubMed ID: 27887795
[TBL] [Abstract][Full Text] [Related]
19. Role of insurance, income, and affordability in human papillomavirus vaccination.
Pourat N; Jones JM
Am J Manag Care; 2012 Jun; 18(6):320-30. PubMed ID: 22775000
[TBL] [Abstract][Full Text] [Related]
20. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
